Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer

Author(s):
Dijk, T.H. van; Tamas, K.; Beukema, J.C.; Beets, G.L.; Gelderblom, A.J. (0000-0001-9270-8636); Jong, K.P. de; Nagtegaal, I.D.; Rutten, H.J.; Velde, C.J.V. de; Wiggers, T.; Hospers, G.A.; Havenga, K.
Published
2013
Publication type
Article / Letter to editor
bevacizumabneoadjuvant chemotherapypreoperative radiotherapyrectal cancerstage IV
Date issued
2013-07-31
Language
English
Is part of
Annals of Oncology (2013), Vol. 24, no. 7, p. 1762-1769
hdl
1887/100090
doi
10.1093/annonc/mdt124